Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Multiple PhD Scholarships available - Cutting-edge research at the frontiers of Whole Cell Modelling
Multiple PhD Scholarships available - Cutting-edge research at the frontiers of Whole Cell Modelling Job No.: 683222 Location: Clayton campus Employment Type: Full-time Duration: 3.5 to 4-year fixed
-
, the challenge is to develop, validate and test a method that offers personalized, tailored travel and route advice in order to stimulate cycling. This four-year PhD project is part of Horizon Europe project Bio
-
the mechanisms governing the formation of the brain during embryonic development and in early postnatal life. This is based on the understanding that early experience shapes the way our brain is constructed. While
-
expertise and supervision of experienced researchers from multiple institutes at Forschungszentrum Jülich. As one of Europe’s largest and most multidisciplinary research centers, Forschungszentrum Jülich
-
health, air quality and noise pollution. In the project Green and safe routing, the challenge is to develop, validate and test a method that offers personalized, tailored travel and route advice in order
-
for Chemical Neuroscience (iCNS )’. Neuropsychiatric disorders are highly prevalent and remain among the leading causes of global disease burden. However, developing effective therapeutics for these disorders is
-
: 01.10.2025 Application deadline: 03.09.2025 Tasks Execution of experimental work in a mouse model of cortical multiple sclerosis Application of in vivo imaging and quantitative analysis methods Investigation
-
domains are e.g., signal-/image processing, artificial intelligence and machine learning. Tasks: research and development in designing and programming field programmable gate arrays (FPGAs) for accelerating
-
We are seeking a highly motivated researcher to conduct research in modelling and monitoring forest growth. About the position The projects focus on developing models for forest types and tree
-
causes of global disease burden. However, developing effective therapeutics for these disorders is challenging, as the underlying molecular mechanisms driving neuropsychiatric symptoms are poorly